These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
These kits are intended for in vitro diagnostic use.
These kits are for research use only and are not intended to be used for diagnostic procedures.
Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
Biological risk products.
Storage between 2 and 8 ° C.
Reactive in liquid form.
Reactive in lyophilized form.
Reactive in frozen form.
Stability after opening at 2-8 ° C.
Products that can be refrozen.
Stability 12 months after refreezing at -20 ° C.
Plasma deficient for protein C inhibitor assay
Human plasma immuno-depleted in protein C and buffered with 20mM HEPES
10 x 1.0 mL
The Safety Data Sheets and Notices are accessible to our registered customers.
Protein C inhibitor (PCI) is a plasma serine protease which primarily inhibits protein C but also inhibits thrombin, FXa, t-PA, trypsin, chymotrypsin.
Its action is amplified in the presence of high concentrations of heparin.
Plasmas verified negative for all tests required by the FDA.
Packaging in plastic cryotubes suitable for all STA-R type micro-cup supports.
The frozen, immuno-depleted plasmas are certified to have less than 1% for the deficient factor considered, both for the antigenic assay and for functional hemostasis.
No bovine additives
No reconstitution error
No deterioration of plasmas linked to freeze-drying